The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 07, 2017

Filed:

Oct. 17, 2014
Applicants:

Abbvie Deutschland Gmbh & Co. KG, Wiesbaden, DE;

Abbvie Inc., North Chicago, IL (US);

Inventors:

Wilhelm Amberg, Ludwigshafen, DE;

Frauke Pohlki, Ludwigshafen, DE;

Udo Lange, Ludwigshafen, DE;

Ying Wang, Libertyville, IL (US);

Jason Brewer, Zion, IL (US);

Anil Vasudevan, Union Grove, WI (US);

Yanbin Lao, North Chicago, IL (US);

Charles Hutchins, Green Oaks, IL (US);

Hongyu Zhao, Libertyville, IL (US);

Huan-Qiu Li, Wilmette, IL (US);

Assignees:

AbbVie Deutschland GmbH & Co. KG, Wiesbaden, DE;

AbbVie Inc., North Chicago, IL (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 403/12 (2006.01); C07D 401/12 (2006.01); C07D 233/42 (2006.01); C07D 207/273 (2006.01); C07D 205/04 (2006.01); C07D 403/14 (2006.01); C07D 403/10 (2006.01); C07D 405/14 (2006.01); A61K 31/4164 (2006.01);
U.S. Cl.
CPC ...
C07D 403/14 (2013.01); C07D 205/04 (2013.01); C07D 207/273 (2013.01); C07D 233/42 (2013.01); C07D 401/12 (2013.01); C07D 403/10 (2013.01); C07D 403/12 (2013.01); C07D 405/14 (2013.01);
Abstract

The present invention relates to aminotetraline and aminoindane derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminotetraline and aminoindane derivatives, and the use of such aminotetraline and aminoindane derivatives for therapeutic purposes. The aminotetraline and aminoindane derivatives are GlyT1 inhibitors.


Find Patent Forward Citations

Loading…